Advances in Developing Small Molecule Drugs for Alzheimer's Disease

被引:0
|
作者
Zhang, Wei [1 ]
Zhang, Liujie [1 ]
Lv, Mingti [1 ,2 ]
Fu, Yun [1 ]
Meng, Xiaowen [1 ]
Wang, Mingyong [3 ,4 ]
Wang, Hecheng [1 ,5 ]
机构
[1] Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Peoples R China
[2] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao, Peoples R China
[3] Xinxiang Med Univ, Sch Med Technol, Xinxiang, Peoples R China
[4] Shangqiu Med Coll, Dept Med Technol, Shangqiu, Henan, Peoples R China
[5] Dalin Univ Technol, Sch Life & Pharmaceut Sci, Panjin, Peoples R China
关键词
Alzheime's disease; computer-aided drug design targets; beta-amyloid; forkhead box protein O1; small molecule drugs; DESIGN; IDENTIFICATION; INHIBITORS; DYNAMICS; FOXO1; QSAR; BETA;
D O I
10.2174/0115672050329828240805074938
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Alzheimer's disease (AD) is the most common type of dementia among middle-aged and elderly individuals. Accelerating the prevention and treatment of AD has become an urgent problem. New technology including Computer-aided drug design (CADD) can effectively reduce the medication cost for patients with AD, reduce the cost of living, and improve the quality of life of patients, providing new ideas for treating AD. This paper reviews the pathogenesis of AD, the latest developments in CADD and other small-molecule docking technologies for drug discovery and development; the current research status of small-molecule compounds for AD at home and abroad from the perspective of drug action targets; the future of AD drug development.
引用
收藏
页码:221 / 231
页数:11
相关论文
共 50 条
  • [1] Small-molecule drugs development for Alzheimer's disease
    Yao, Weiwei
    Yang, Huihui
    Yang, Jinfei
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [2] Discovery of ADDL-targeting small molecule drugs for Alzheimer's disease
    Look, Gary C.
    Jerecic, Jasna
    Cherbavaz, Diana B.
    Pray, Todd R.
    Breach, Jean-Claude R.
    Crosier, Walter J.
    Igoudin, Lev
    Hironaka, Catherine M.
    Lowe, Raymond M.
    McEntee, Michele
    Ruslim-Litrus, Lily
    Wu, Hsiu-Mei
    Zhang, Sue
    Catalano, Susan M.
    Goure, William F.
    Summa, David
    Krafft, Grant A.
    CURRENT ALZHEIMER RESEARCH, 2007, 4 (05) : 562 - 567
  • [3] Recent advances of small molecule JNK3 inhibitors for Alzheimer?s disease
    Qin, Pengxia
    Ran, Yingying
    Liu, Yujing
    Wei, Chao
    Luan, Xiaoyi
    Niu, Haoqian
    Peng, Jie
    Sun, Jie
    Wu, Jingde
    BIOORGANIC CHEMISTRY, 2022, 128
  • [4] Small Molecule Therapeutics for Alzheimer's Disease
    Ma, Dik-Lung
    Leung, Chung-Hang
    CURRENT ALZHEIMER RESEARCH, 2015, 12 (05) : 400 - 402
  • [5] Small molecule biomarkers in Alzheimer's disease
    Kim, Min
    Legido-Quigley, Cristina
    OCL-OILSEEDS AND FATS CROPS AND LIPIDS, 2018, 25 (04)
  • [6] Advances in developing therapeutic strategies for Alzheimer's disease
    Nguyen, Thuy Trang
    Nguyen, Thi Thuy Dung
    Nguyen, Thi Kim Oanh
    Vo, Tuong Kha
    Vo, Van Giau
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [7] Antihypertensive drugs and the risk of developing Alzheimer's disease
    Imfeld, P.
    Brauchli, Y. B.
    Jick, S. S.
    Meier, C. R.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 409 - 409
  • [8] Small Molecule Natural Products and Alzheimer's Disease
    Wu, Xiaoai
    Cai, Huawei
    Pan, Lili
    Cui, Gang
    Qin, Feng
    Li, YunChun
    Cai, Zhengxin
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (03) : 187 - 204
  • [9] Small-molecule theranostics in Alzheimer's disease
    Sarabia-Vallejo, Alvaro
    Lopez-Alvarado, Pilar
    Menendez, J. Carlos
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 255
  • [10] Current advances in transdermal delivery of drugs for Alzheimer's disease
    Thuy Trang Nguyen
    Vo Van Giau
    Tuong Kha Vo
    INDIAN JOURNAL OF PHARMACOLOGY, 2017, 49 (02) : 145 - 154